Investment Team

Active Responsibilities
Select Prior Responsibilities

Richard S. Kollender

  • Joined Quaker Partners in 2003 and promoted to Partner in 2005
  • Previously: Held positions in sales, marketing and worldwide business development at GlaxoSmithKline. Also served as investment manager at S.R. One where he evaluated potential investment opportunities, performed due diligence, structured and negotiated investments and worked with management teams to execute their strategies following investment. Began his career as a CPA with KPMG Peat Marwick with an emphasis on the healthcare and emerging businesses sectors.
  • Active Responsibilities: Rapid Micro Biosystems
  • Select Prior Responsibilities: Achillion Pharmaceuticals (acquired by Alexion), Horizon Therapeutics, Insmed (NASDAQ: INSM), Medmark (acquired by Walgreen Co.) and NuPathe (acquired by Teva)
  • Other: President and Chief Financial Officer, Strongbridge Biopharma (Nasdaq: SBBP); Chairman, Restorative Therapies; Board of Trustees, Abramson Senior Care; Certified Public Accountant. Member of both the American and Pennsylvania Institutes of Certified Public Accountants; Adjunct faculty, Lehigh University.
  • Education: B.A. from Franklin and Marshall College, M.B.A. and Health Administration & Policy degrees with Honors from the University of Chicago